Shilpa Medicare secures CDSCO’s nod for fatty liver drug, shares spike 8%

Non-alcoholic fatty liver disease (NAFLD) affects nearly 19 crore people in India and about a quarter of the world’s population.

Leave a Reply

Your email address will not be published. Required fields are marked *